Cell & Gene Therapy Drug Delivery Devices Market Analysis and Growth Forecast by 2030

MarkNtel Advisors, a leading market research and consulting firm, has announced the release of its latest study titled Cell & Gene Therapy Drug Delivery Devices Market Research Report: Forecast (2025–2030). This report provides a detailed assessment of the Cell & Gene Therapy Drug Delivery Devices, covering its evolving dynamics, emerging trends, key growth drivers, major challenges, and competitive landscape.

Designed to guide investors, stakeholders, and business leaders, the research aims to deliver valuable insights for strategic planning, risk assessment, and investment decision-making in the years ahead.

Cell & Gene Therapy Drug Delivery Devices Market Timeline Overview

• Historical Years: 2020–23

• Base Year: 2024

• Forecast Years: 2025–2030

This helps businesses identify emerging opportunities, assess market risks, and develop data-driven strategies for long-term success.

Download a FREE PDF Sample of the Report: - https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html   (Discover the market potential, platform-specific insights, and key industry trends.)

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Cell & Gene Therapy Drug Delivery Devices Market Outlook

The Global Cell & Gene Therapy Drug Delivery Devices Market size was valued at around USD 1.27 billion in 2024 and is projected to reach USD 2.32 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.53% during the forecast period, i.e., 2025-30.

The market is driven primarily by massive funding by numerous leading players in the technological advancements to bring cost-effective therapies & devices, coupled with the increasing number of FDA approvals for cell & gene therapies & clinical trials. Furthermore, the rising number of FDA Approvals of Cell & Gene Therapies and clinical trials to develop new medical products and provide patients with increased therapeutic choices shall also boost the market in the coming years

Cell & Gene Therapy Drug Delivery Devices Market Drivers:

Growing Occurrence of Chronic and Genetic Disorders – One of the leading drivers propelling the global cell and gene therapy drug delivery devices market is the increasing prevalence of chronic diseases, particularly cancer, diabetes, and genetic disorders. As these complex conditions become more widespread, there is a growing demand for advanced therapies that can offer targeted and effective treatment options. Cell and gene therapies have emerged as transformative solutions, and their success relies heavily on innovative drug delivery devices that ensure precise administration, optimal dosage, and improved patient outcomes. This surge in chronic disease cases not only fuels the adoption of these therapies but also accelerates the development and deployment of specialized delivery devices, thereby driving robust market growth.

View Full Report (All Data, In One Place): - https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html   (Explore in-depth analyses, technological trends, and investment patterns.)

Cell & Gene Therapy Drug Delivery Devices Market Trends:

Shift Toward Personalized and Targeted Therapies – The most significant trend shaping the market is the growing shift toward personalized and targeted therapies. As biotechnology and genetic engineering advance, there is a heightened focus on developing delivery systems that can precisely administer cell and gene therapies tailored to individual patient profiles. This trend is supported by increased investment in research and development, as well as the creation of novel delivery platforms that enhance treatment efficacy and safety.

Cell & Gene Therapy Drug Delivery Devices Market Segmentation

The study categorizes the Cell & Gene Therapy Drug Delivery Devices Market into various segments and sub-segments, each analyzed for its size, growth potential, and contribution to the overall industry.

By Product Type

• Sub-retinal Injection Cannula

• Extension Tube

• Intravenous Catheter

• Sterile Insulin Syringe

  • Size 1.0 ML, 31-Gauge Needle

  • Size 0.5 ML, 22-Gauge Needle

• Pre-Filled Syringe

  • Size 1.0 ML, 22-26 Gauge Needle

  • Size 4.0 ML, 22-26 Gauge Needle

• Infusion Bags

  • Infusion Bags (Size 10 ML to 50 ML)

  • Infusion Bags (Size 68 ML)

  • Infusion Bags (Size 60 ML)

  • Infusion Bags (Size Up to 65 ML)

By Technology

• Microchip Technology

• Nano-Technology

• Lipid Nanoparticles

By Commercialized Drugs

• Luxturna

• Kymriah

• Yescarta

• Zolgensma

• Provenge

• Strimvelis

By End-User

• Pharmaceuticals & Biotechnology Company

• Academic & Research Institute

• Hospitals & Clinics

Geographical Analysis

The report presents detailed insights into the market’s geographical expansion, highlighting key trends and opportunities across the following geographies:

By Region

• North America

• South America

• Europe

• Middle East & Africa

• Asia-Pacific.

Talk to Our Industry Analyst:  - https://www.marknteladvisors.com/query/talk-to-our-consultant/cell-gene-therapy-drug-delivery-devices-market.html  Get personalized insights into company strategies and regional market dynamics.)

Leading Companies in Cell & Gene Therapy Drug Delivery Devices Market Worldwide: Players, Analysis & Future Outlook

• Amgen Inc.

• Bausch & Lomb Incorporated

• Becton, Dickinson and Company

• Bluebird bio Inc.

• Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)

• Dendreon Pharmaceuticals LLC

• Helixmith Co. Ltd (ViroMed Co., Ltd)

• Human Stem Cells Institute

• Kite Pharma Inc.

• Kolon TissueGene, Inc.

• Novartis AG

• Orchard Therapeutics plc.

• Pfizer Inc.

• Renova Therapeutics

• Spark Therapeutics Inc.

• uniQure N.V.

• Vericel Corporation.

Key Highlights of the Report

• Comprehensive Market Overview: In-depth analysis of market size, share, and forecasts from 2025 to 2030.

• Growth Drivers & Challenges: Clear insights into factors feeling or restraining market expansion.

• Investment & Regulatory Insights: Evaluation of key policies, funding trends, and collaborations influencing industry performance.

• Competitive Landscape: Detailed profiles of leading companies, including product portfolios, business strategies, financials, and recent developments such as mergers & acquisitions.

Analytical Tools: Application of SWOT Analysis, PESTEL Analysis, and Porter’s Five Forces Model to assess competition and external influences

Browse through our flexible pricing plans and choose the package that best fits your business needs whether you require a single-user license, corporate access, or customized insights. Once you select the plan that suits your requirements, you can purchase and instantly access the full report online – https://www.marknteladvisors.com/pricing/cell-gene-therapy-drug-delivery-devices-market.html   

Frequently Asked Questions (FAQ)

1. What is the projected growth rate of the Cell & Gene Therapy Drug Delivery Devices Market?

   
   

    2. What are the major factors driving this market’s growth?

   
   

    3. Which regions are expected to lead the Cell & Gene Therapy Drug Delivery Devices Market?

   
   

    4. Who are the prominent players in the Cell & Gene Therapy Drug Delivery Devices Market?

   
   

    5. How is the competition structured in this market?

   
   

    6. How can I access the full report?

About Us

MarkNtel Advisors is a globally recognized market research and consulting firm delivering intelligence across the healthcare industry, spanning pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our analysts combine domain expertise with innovation tracking to help healthcare organizations improve efficiency and patient outcomes. Through Consulting Services, we assist clients in interpreting insights, designing go-to-market strategies, and adapting to regulatory changes, fostering sustainable growth in the evolving global healthcare ecosystem.

Contact Us: MarkNtel Advisors Sector 63, Noida, Uttar Pradesh-201301, India Contact No: +91 87199 99009 Email: sales@marknteladvisors.com Website: https://www.marknteladvisors.com